Evidera
See the following -
Avanir Pharmaceuticals Presents Data From A Benchmark Study Of PBA Symptoms In Veterans With Mild Traumatic Brain Injury
Press Release |
Avanir Pharmaceuticals, Inc. |
March 19, 2014
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the presentation of results from a first-of-its-kind study of pseudobulbar affect (PBA) symptoms in veterans with mild traumatic brain injury (TBI) conducted in collaboration with the Department of Veterans Affairs (VA) and Evidera. Read More »
- Login to post comments